Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States.

By C. Ruhl, J. Everhart. Gastroenterology, 2003

628 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/d35b685056b8e9e52fddea564536f51eacda2fdb

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. Z. Younossi
2. J. Clark
3. A. Baranova
4. S. Grundy
5. J. Ong
6. G. Vernon
7. A. Pitts
8. Gerald I. Shulman

In Epidemiology

1. Z. Younossi
2. J. Clark
3. A. Baranova
4. Sushil Kumar Jain
5. Prasenjit Manna
6. J. Browning
7. S. Grundy
8. J. Ong

In Pathology and Forensic Medicine

1. Z. Younossi
2. J. Clark
3. A. Baranova
4. Sushil Kumar Jain
5. J. Ong
6. G. Vernon
7. A. Pitts

Citations in the corpus

• Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. (2008, methodology): “Moreover, this definition of NAFLD has been employed in many published epidemiological studies of NAFLD [16–19].”
• Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. (2005, methodology): “In the Third National Health and Nutrition Examination Survey (37), the estimated prevalence of hepatic steatosis was 2.”
• Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms (2005, neutral): “16% a BMI<25 [14].”
• The Epidemiology of Nonalcoholic Fatty Liver Disease in Adults (2006, background): “syndrome.(21,24,51,52) The relative importance of each of these factors is difficult to determine, however, since they often coexist.”
• Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults (2011, methodology): “Data from the US National Health and Nutrition Examination Survey (1988–1994) reported elevated ALT levels in 3% of the population.(17) The 1999–2002 National Health and Nutrition Examination Survey”
• Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies (2015, background): “The prevalence of NAFLD increases with the increase in BMI.176 Among nonobese subjects, the rates of occurrence of steatosis and steatohepatitis were *15% and 3%, respectively; however, in subjects with BMI between 30 and 39.9, the prevalence rates were 65% and 20%, respectively, and in extremely ob”